Research Field

Research Field Cell & gene therapy

Perusing the Pipeline

| James Strachan

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.

Research Field Cell & gene therapy

Swimming against the nucleotides

| James Bainbridge

Tomorrow’s cures for retinopathies will likely include advanced gene and cell therapies delivered by precision surgery.

Research Field Microbiology

Monitoring the Microbiome

| Luke Turner

Differences in bacterial diversity in the gut could be used to identify patients with Barrett’s esophagus and esophageal cancer.

Research Field Gene Editing

It's CRISPR Crunch Time

| Jonathan James

China drafts new gene-editing regulations – but concerns over their enforcement remain.

Research Field Drug discovery

The Centryin of Attention

| Jonathan James

A novel protein platform helps neutralize powerful MRSA toxins.

Research Field Cell & gene therapy

Now For the High-Hanging Fruit

| Miguel Forte

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

Research Field Gene Editing

Dinner with a CRISPR Connoisseur

| Jonathan James

Harvard Medical School’s Richard Sherwood digs into the potential and pitfalls of gene editing technology.

Research Field Drug discovery

DONs Potential Unfolds

| Jonathan James

How DNA origami nanostructures could find their way into the treatment of acute kidney injury.

Research Field Cell & molecular biology

H(eye) - or Low?

| Phoebe Harkin

Two chemical components; opposite effects. How medical marijuana impacts glaucoma for better – and for worse.

Research Field Neuroscience

Building up to a breakthrough

| Jonathan James

We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register